13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-09-04 Event — SEC 0000921895-26-002494 →

Whitefort Capital Management, LP Arbutus Biopharma Corp ABUS

Stake: Shares: CUSIP: 03879J100 Class: Common Shares, without par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
26 13D/G filings on this issuer
25 other filings besides this one
Filer Track Record
4 filings by this filer
3 other filings in the data moat
Short Interest · settle 2026-08-14
DTC 15.10
18,456,085 shares short · -8.8% vs prior

Other 13D/G Filings on Arbutus Biopharma Corp

FiledFormFilerStakeShares
2026-04-28 SCHEDULE 13D/A Whitefort Capital Management, LP 15,794,261 view →
2026-04-13 SCHEDULE 13D/A Whitefort Capital Management, LP 8.10% 15,794,261 view →
2025-02-25 SCHEDULE Roivant Sciences Ltd. 20.50% 38,847,462 view →
2025-02-21 SCHEDULE Whitefort Capital Management, LP 7.00% 13,307,967 view →
2025-02-18 SCHEDULE Roivant Sciences Ltd. 20.50% 38,847,462 view →
2021-10-20 SC Roivant Sciences Ltd. view →
2019-07-17 SC Machado Patrick view →
2019-07-17 SC Lo Andrew view →
2019-07-16 SC Roivant Sciences Ltd. view →
2019-07-12 SC VIKING GLOBAL INVESTORS LP view →
2019-07-12 SC Dexxon Holdings Ltd. view →
2019-07-12 SC SVF Investments (UK) Ltd view →
2019-07-12 SC QVT Financial LP view →
2019-01-03 SC VIKING GLOBAL INVESTORS LP view →
2018-04-23 SC Roivant Sciences Ltd. view →
2018-04-12 SC Roivant Sciences Ltd. view →
2018-03-16 SC Roivant Sciences Ltd. view →
2018-02-14 SC Roivant Sciences Ltd. view →
2018-01-16 SC Machado Patrick view →
2018-01-16 SC VIKING GLOBAL INVESTORS LP view →
Showing 20 of 25

Other Filings by Whitefort Capital Management, LP

FiledFormIssuerStakeShares
2026-04-28 SCHEDULE 13D/A Arbutus Biopharma Corp ABUS 15,794,261 view →
2026-04-13 SCHEDULE 13D/A Arbutus Biopharma Corp ABUS 8.10% 15,794,261 view →
2025-02-21 SCHEDULE Arbutus Biopharma Corp ABUS 7.00% 13,307,967 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →